GSK in the United Kingdom is seeking an Asset Study Delivery Lead for a 14-month secondment/FTC to drive end-to-end portfolio delivery for Therapeutic Area studies.
You will coordinate proposal reviews with matrix stakeholders, forecast budgets, manage study portfolios, and lead cross-functional collaboration across internal teams and external partners.
The role requires strong GCP knowledge, supplier management, and the ability to drive performance in a complex, matrix environment.
#J-18808-Ljbffr
Asset Study Portfolio Lead - Hybrid Delivery & Strategy employer: GlaxoSmithKline
GlaxoSmithKline is an exceptional employer that prioritises employee growth and development, offering a dynamic work culture where collaboration and innovation thrive. With a hybrid working model based in the UK, employees benefit from flexible working arrangements while contributing to meaningful projects that enhance patient safety globally. The company fosters a supportive environment that encourages continuous learning and professional advancement, making it an ideal place for those passionate about making a difference in healthcare.
